Caribou Biosciences, Inc. (CRBU)
1.70
-0.02
(-1.16%)
USD |
NASDAQ |
Dec 26, 16:00
1.70
0.00 (0.00%)
After-Hours: 20:00
Caribou Biosciences Shareholders Equity (Quarterly): 141.84M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | 45.63M |
| GT Biopharma, Inc. | 3.00M |
| Phio Pharmaceuticals Corp. | 9.839M |
| Daré Bioscience, Inc. | 2.858M |
| Nurix Therapeutics, Inc. | 372.25M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 194.98M |
| Total Liabilities (Quarterly) | 53.14M |
| Debt to Equity Ratio | 0.1795 |
| Current Ratio | 5.542 |
| Net Debt Paydown Yield | 0.17% |